Pharmaceutical Technology, Mar 1, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Mar 1, 2013
Articles
Advancing Polymers for Solubility Enhancement
By Adeline Siew, PhD
Pharmaceutical Technology brought together a panel of industry experts for a special forum to discuss solubilizing polymers and the related formulation strategies for poorly soluble drugs.
Continuous Improvement in Tablet Coating and Dry Granulation
By Martin Hack , Dejan Djuric
Recent advances in equipment design and operation in spraying, drying, and mixing can improve the tablet-coating process.
Standardizing Excipient Information to Achieve Supply-Chain Security
By Bretta Erskine Lichtenhan
The use of various documents and guides by the International Pharmaceutical Excipients Council can facilitate the flow of information among excipient manufacturers, distributors, and users.
Tackling Common Problems in Tableting and Tooling
By Adeline Siew, PhD
The tableting science anti-research (TSAR) project seeks to understand why certain formulations stick to tablet tooling.
Quality by Design in Excipients
By Patricia Van Arnum
Factors for assessing excipient variability, the associated challenges developers need to address to design and manufacture solid oral drug products, and solutions for such challenges are examined.
Concerns and Innovations in Tablet Splitting and Scoring
A roundtable discussion of the challenges and innovations in tablet splitting featuring Freeman Technology, Accu-Break Pharmaceuticals, and Medelpharm.
The Ph.Eur. approach to tablet splitting
An alternative chapter has been added to the European Pharmacopoeia for dosage uniformity.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here